ALLMedicine™ Prostatic Hyperplasia Center
Research & Reviews 3,457 results
https://doi.org/10.1080/01480545.2021.1892956
Drug and Chemical Toxicology; Eleazu K, Maduabuchi Aja P et. al.
Mar 1st, 2021 - The increased global prevalence of benign prostatic hyperplasia (BPH) and the promising potentials of functional foods in ameliorating it led to this study which reported the effect of aqueous ethanol extract of cocoyam (Colocasia esculenta) tuber...
https://doi.org/10.1208/s12248-021-00568-y 10.1016/S0022-5347(17)49698-4 10.1016/S0025-7125(05)70159-0 10.1016/S0022-5347(17)36966-5 10.1007/s11934-012-0286-5 10.1016/S0022-5347(01)66780-6 10.1111/j.1464-410X.2008.07574.x 10.1208/s12248-019-0370-6 10.1208/s12248-019-0343-9 10.1208/s12248-020-00500-w 10.1208/s12248-020-00484-7 10.1038/clpt.1994.142 10.1002/cpt.1595 10.1038/psp.2013.24 10.1023/A:1020561807903 10.1007/s10928-009-9112-1 10.1111/j.1541-0420.2007.00782.x 10.1016/j.jml.2012.11.001 10.1016/S0022-5371(73)80014-3 10.1016/j.tree.2008.10.008 10.1007/s10928-017-9531-3 10.1023/A:1020254823597 10.1037/1082-989X.11.1.54 10.1002/sim.4155 10.1007/s10928-011-9205-5
The AAPS Journal; Lyauk YK, Jonker DM et. al.
Feb 25th, 2021 - The International Prostate Symptom Score (IPSS), the quality of life (QoL) score, and the benign prostatic hyperplasia impact index (BII) are three different scales commonly used to assess the severity of lower urinary tract symptoms associated wi...
https://doi.org/10.1186/s12894-021-00797-5 10.23736/S0393-2249.19.03589-6 10.1007/s00345-009-0503-0 10.1007/s00345-020-03137-8 10.1159/000019535 10.1016/j.eururo.2014.06.017 10.1097/01.ju.0000113494.03668.6d 10.1089/end.1995.9.151 10.1097/JU.0000000000000873.01 10.18565/urology.2018.1.42-47 10.1016/S0022-5347(05)00645-2 10.1007/s00345-017-2129-y 10.1016/j.juro.2011.06.063 10.1097/01.ju.0000140501.68841.a1 10.1111/j.1464-410X.2007.06867.x 10.1016/j.urology.2018.06.012 10.1016/j.urology.2018.07.010 10.1007/s00345-017-2159-5 10.5041/RMMJ.10315 10.1097/MOU.0000000000000710 10.1016/j.urology.2019.11.029 10.1016/j.acuro.2016.06.010
BMC Urology; Bozzini G, Maltagliati M et. al.
Feb 24th, 2021 - To compare clinical intra and early postoperative outcomes between conventional Holmium laser enucleation of the prostate (HoLEP) and Holmium laser enucleation of the prostate using the Virtual Basket tool (VB-HoLEP) to treat benign prostatic hype...
https://doi.org/10.1097/JU.0000000000001693
The Journal of Urology; Kavoussi NL, Nimmagadda N et. al.
Feb 22nd, 2021 - Holmium laser enucleation of the prostate (HoLEP) has proven to be efficacious and safe for the treatment of benign prostatic hyperplasia (BPH). New laser technologies, such as the MOSES™ Pulse laser system, improve energy delivery and may improve...
https://doi.org/10.1097/JU.0000000000001640
The Journal of Urology; Kuhlmann PK, Fischer SC et. al.
Feb 19th, 2021 - In men, complaints of nocturia causing poor sleep are often attributed to benign prostatic hyperplasia (BPH) and treated with BPH medications. We assessed whether treating lower urinary tract symptoms (LUTS) with dutasteride altered either nocturi...
Guidelines 7 results
https://doi.org/10.1097/JU.0000000000001298
The Journal of Urology; Parsons JK, Dahm P et. al.
Jul 23rd, 2020 - The AUA Guideline panel provides evidence-based recommendations for the surgical management of male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The Panel amended the Guideline in 2020 to reflect additional ...
https://doi.org/10.1097/JU.0000000000000319
The Journal of Urology; Foster HE, Dahm P et. al.
May 6th, 2019 - Male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is common in men and can have negative effects on quality of life (QoL). It is the hope that this Guideline becomes a reference for effective evidence-based s...
https://doi.org/10.1016/j.juro.2018.05.048
The Journal of Urology; Foster HE, Barry MJ et. al.
May 18th, 2018 - Male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is common in men and can have negative effects on quality of life (QoL). It is the hope that this Guideline becomes a reference on the effective evidence-base...
http://www.auanet.org/guidelines/benign-prostatic-hyperplasia/lower-urinary-tract-symptoms-(2018)
Harris E. Foster
Apr 30th, 2018 - Benign prostatic hyperplasia (BPH) is a histologic diagnosis that refers to the proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The prevalence and the severity of lower urinary tract symptoms (LUTS) in the.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778754
Investigative and Clinical Urology; Yeo JK, Choi H et. al.
Mar 11th, 2016 - In 2014, the Korean Urological Association organized the Benign Prostatic Hyperplasia Guideline Developing Committee composed of experts in the field of benign prostatic hyperplasia (BPH) with the participation of the Korean Academy of Family Medi...
Drugs 789 results see all →
Clinicaltrials.gov 4,341 results
https://doi.org/10.1080/01480545.2021.1892956
Drug and Chemical Toxicology; Eleazu K, Maduabuchi Aja P et. al.
Mar 1st, 2021 - The increased global prevalence of benign prostatic hyperplasia (BPH) and the promising potentials of functional foods in ameliorating it led to this study which reported the effect of aqueous ethanol extract of cocoyam (Colocasia esculenta) tuber...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2300db48-477f-4357-8de9-f723737071b4
Feb 28th, 2021 - Silodosin capsules, an alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Silodosin capsule is not indicated for the treatment of hypertension. (1) Silodosin caps...
https://doi.org/10.1208/s12248-021-00568-y 10.1016/S0022-5347(17)49698-4 10.1016/S0025-7125(05)70159-0 10.1016/S0022-5347(17)36966-5 10.1007/s11934-012-0286-5 10.1016/S0022-5347(01)66780-6 10.1111/j.1464-410X.2008.07574.x 10.1208/s12248-019-0370-6 10.1208/s12248-019-0343-9 10.1208/s12248-020-00500-w 10.1208/s12248-020-00484-7 10.1038/clpt.1994.142 10.1002/cpt.1595 10.1038/psp.2013.24 10.1023/A:1020561807903 10.1007/s10928-009-9112-1 10.1111/j.1541-0420.2007.00782.x 10.1016/j.jml.2012.11.001 10.1016/S0022-5371(73)80014-3 10.1016/j.tree.2008.10.008 10.1007/s10928-017-9531-3 10.1023/A:1020254823597 10.1037/1082-989X.11.1.54 10.1002/sim.4155 10.1007/s10928-011-9205-5
The AAPS Journal; Lyauk YK, Jonker DM et. al.
Feb 25th, 2021 - The International Prostate Symptom Score (IPSS), the quality of life (QoL) score, and the benign prostatic hyperplasia impact index (BII) are three different scales commonly used to assess the severity of lower urinary tract symptoms associated wi...
https://doi.org/10.1186/s12894-021-00797-5 10.23736/S0393-2249.19.03589-6 10.1007/s00345-009-0503-0 10.1007/s00345-020-03137-8 10.1159/000019535 10.1016/j.eururo.2014.06.017 10.1097/01.ju.0000113494.03668.6d 10.1089/end.1995.9.151 10.1097/JU.0000000000000873.01 10.18565/urology.2018.1.42-47 10.1016/S0022-5347(05)00645-2 10.1007/s00345-017-2129-y 10.1016/j.juro.2011.06.063 10.1097/01.ju.0000140501.68841.a1 10.1111/j.1464-410X.2007.06867.x 10.1016/j.urology.2018.06.012 10.1016/j.urology.2018.07.010 10.1007/s00345-017-2159-5 10.5041/RMMJ.10315 10.1097/MOU.0000000000000710 10.1016/j.urology.2019.11.029 10.1016/j.acuro.2016.06.010
BMC Urology; Bozzini G, Maltagliati M et. al.
Feb 24th, 2021 - To compare clinical intra and early postoperative outcomes between conventional Holmium laser enucleation of the prostate (HoLEP) and Holmium laser enucleation of the prostate using the Virtual Basket tool (VB-HoLEP) to treat benign prostatic hype...
https://www.medscape.com/viewarticle/946349
Feb 24th, 2021 - NEW YORK (Reuters Health) - Photoselective vaporization of the prostate can provide relief from refractory lower-urinary-tract symptoms (LUTS) resulting from benign prostatic hyperplasia (BPH) in prostate cancer patients managed by active surveill...
News 81 results
https://www.medscape.com/viewarticle/946349
Feb 24th, 2021 - NEW YORK (Reuters Health) - Photoselective vaporization of the prostate can provide relief from refractory lower-urinary-tract symptoms (LUTS) resulting from benign prostatic hyperplasia (BPH) in prostate cancer patients managed by active surveill...
https://www.medscape.com/viewarticle/945551
Feb 8th, 2021 - Certain drugs currently used to treat benign prostatic hyperplasia (BPH) may provide neuroprotection and delay or prevent the onset of Parkinson's disease, new research suggests. Treatment of BPH with terazosin (Hytrin), doxazosin (Cardura), or al...
https://reference.medscape.com/viewarticle/943651
Jan 11th, 2021 - Benign prostatic hyperplasia (BPH) is present in as many as 60% of men in their 60s and 90% of men older than 70 years. BPH describes nonmalignant prostate tissue growth and commonly causes lower urinary tract symptoms (LUTS). Not all men with BPH...
https://www.staging.medscape.com/viewarticle/941123
Nov 18th, 2020 - NEW YORK (Reuters Health) - Urethral-sparing robot-assisted simple prostatectomy (usRASP) preserves ejaculatory function while relieving lower-urinary-tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH), according to findings from...
https://www.medscape.com/viewarticle/941123
Nov 18th, 2020 - NEW YORK (Reuters Health) - Urethral-sparing robot-assisted simple prostatectomy (usRASP) preserves ejaculatory function while relieving lower-urinary-tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH), according to findings from...
